Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Cancers|April 30, 2021
Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent PathwaysAshok Narasimhan, Xiaoling Zhong, Ernie P Au, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
BMC Genomics|May 14, 2024
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
Oncotarget|July 23, 2016
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancersMilan Radovich, Patrick J Kiel, Stacy M Nance, et al.
JCO Precision Oncology|March 23, 2022
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated CancersMohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist|June 5, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancerHanna K Sanoff, Allison M Deal, Jai Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomasTanios Bekaii-Saab, Joseph Markowitz, Nichole Prescott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
Cancers|June 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary CancersGentry G King, Kelsey K Baker, Andrew L Coveler, et al.
Pageof 7